{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:10:13Z","timestamp":1792458613274,"version":"4.5.0"},"reference-count":239,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cyto.2021.155781","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T19:24:30Z","timestamp":1639682670000},"page":"155781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Balance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases"],"prefix":"10.1016","volume":"150","author":[{"given":"Mathilde","family":"Harel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Fauteux-Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Girard-Guyonvarc'h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-3063","authenticated-orcid":false,"given":"Cem","family":"Gabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.06.017","article-title":"The interleukin (IL)-1 cytokine family\u2013Balance between agonists and antagonists in inflammatory diseases","volume":"76","author":"Palomo","year":"2015","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0010","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/iai.57.2.590-595.1989","article-title":"Endotoxin-induced serum factor that stimulates gamma interferon production","volume":"57","author":"Nakamura","year":"1989","journal-title":"Infect Immun."},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","article-title":"Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response","volume":"10","author":"Novick","year":"1999","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0020","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated serum levels of free interleukin-18 in adult-onset Still's disease","volume":"55","author":"Girard","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"13","key":"10.1016\/j.cyto.2021.155781_b0025","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0030","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4049\/jimmunol.2000168","article-title":"Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome","volume":"205","author":"Harel","year":"2020","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/kez284","article-title":"IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/rheumatology\/kez282","article-title":"IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1128\/iai.61.1.64-70.1993","article-title":"Purification of a factor which provides a costimulatory signal for gamma interferon production","volume":"61","author":"Nakamura","year":"1993","journal-title":"Infect Immun."},{"issue":"6552","key":"10.1016\/j.cyto.2021.155781_b0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"issue":"6566","key":"10.1016\/j.cyto.2021.155781_b0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/379591a0","article-title":"A newly defined interleukin-1?","volume":"379","author":"Bazan","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4049\/jimmunol.163.1.143","article-title":"Bioactive IL-18 expression is up-regulated in Crohn's disease","volume":"163","author":"Monteleone","year":"1999","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0065","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.4049\/jimmunol.162.12.7322","article-title":"Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway","volume":"162","author":"Pirhonen","year":"1999","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0070","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1073\/pnas.96.5.2256","article-title":"Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells","volume":"96","author":"Puren","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0075","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.4049\/jimmunol.167.12.7060","article-title":"Role of IL-18 in acute lung inflammation","volume":"167","author":"Jordan","year":"2001","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2021.155781_b0080","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1128\/IAI.71.8.4382-4388.2003","article-title":"Human alveolar macrophages infected by virulent bacteria expressing SipB are a major source of active interleukin-18","volume":"71","author":"Obregon","year":"2003","journal-title":"Infect Immun."},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1462-5822.2005.00621.x","article-title":"Interleukin-18 secretion and Th1-like cytokine responses in human peripheral blood mononuclear cells under the influence of the toll-like receptor-5 ligand flagellin","volume":"8","author":"Bachmann","year":"2006","journal-title":"Cell Microbiol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.immuni.2015.01.011","article-title":"Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection","volume":"42","author":"Munoz","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0095","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0006-291X(03)00496-0","article-title":"TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation","volume":"303","author":"Chandrasekar","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/jir.2006.0130","article-title":"Constitutive expression of IL-18 and IL-18R in differentiated IEC-6 cells: effect of TNF-alpha and IFN-gamma treatment","volume":"28","author":"Kolinska","year":"2008","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1096\/fj.08-110213","article-title":"Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils","volume":"23","author":"Fortin","year":"2009","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0110","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1074\/jbc.272.4.2035","article-title":"Induction of interferon-gamma inducing factor in the adrenal cortex","volume":"272","author":"Conti","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0115","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4049\/jimmunol.159.1.298","article-title":"Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes","volume":"159","author":"Stoll","year":"1997","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s004410051373","article-title":"Intracellular production of interleukin-18 in human epithelial-like cell lines is enhanced by hyperosmotic stress in vitro","volume":"297","author":"Takeuchi","year":"1999","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.cyto.2021.155781_b0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","article-title":"Interleukin-18 regulates both Th1 and Th2 responses","volume":"19","author":"Nakanishi","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/clim.1998.4633","article-title":"Regulation of human IL-18 mRNA expression","volume":"90","author":"Marshall","year":"1999","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/eji.200324420","article-title":"Regulation of human IL-18 gene expression: interaction of PU.1 with GC-box binding protein is involved in human IL-18 expression in myeloid cells","volume":"34","author":"Koyama","year":"2004","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0140","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.163.4.2000","article-title":"Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression","volume":"163","author":"Kim","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.gene.6364366","article-title":"Interleukin-18 genetics and inflammatory disease susceptibility","volume":"8","author":"Thompson","year":"2007","journal-title":"Genes Immun"},{"issue":"6625","key":"10.1016\/j.cyto.2021.155781_b0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/386619a0","article-title":"Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production","volume":"386","author":"Ghayur","year":"1997","journal-title":"Nature"},{"issue":"5297","key":"10.1016\/j.cyto.2021.155781_b0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","article-title":"Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme","volume":"275","author":"Gu","year":"1997","journal-title":"Science"},{"issue":"42","key":"10.1016\/j.cyto.2021.155781_b0160","doi-asserted-by":"crossref","first-page":"26595","DOI":"10.1074\/jbc.272.42.26595","article-title":"Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells","volume":"272","author":"Akita","year":"1997","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1020506300324","article-title":"Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1)","volume":"19","author":"Fantuzzi","year":"1999","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0170","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/eji.201747404","article-title":"The Gasdermin-D pore acts as a conduit for IL-1beta secretion in mice","volume":"48","author":"Heilig","year":"2018","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0175","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.4049\/jimmunol.1202121","article-title":"Cutting edge: FAS (CD95) mediates noncanonical IL-1beta and IL-18 maturation via caspase-8 in an RIP3-independent manner","volume":"189","author":"Bossaller","year":"2012","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.cyto.2021.155781_b0180","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.4049\/jimmunol.1203059","article-title":"Fas-mediated inflammatory response in Listeria monocytogenes infection","volume":"190","author":"Uchiyama","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajpath.2014.08.025","article-title":"Novel roles for caspase-8 in IL-1beta and inflammasome regulation","volume":"185","author":"Gurung","year":"2015","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.cyto.2021.155781_b0190","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.4049\/jimmunol.167.11.6568","article-title":"Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells","volume":"167","author":"Sugawara","year":"2001","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0195","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.4049\/jimmunol.177.12.8315","article-title":"Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment","volume":"177","author":"Omoto","year":"2006","journal-title":"J Immunol"},{"issue":"46","key":"10.1016\/j.cyto.2021.155781_b0200","doi-asserted-by":"crossref","first-page":"31371","DOI":"10.1074\/jbc.M802814200","article-title":"Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation","volume":"283","author":"Banerjee","year":"2008","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jdermsci.2010.05.004","article-title":"Granzyme B is a novel interleukin-18 converting enzyme","volume":"59","author":"Omoto","year":"2010","journal-title":"J Dermatol Sci"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0210","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jlb.63.6.658","article-title":"Overview of interleukin-18: more than an interferon-gamma inducing factor","volume":"63","author":"Dinarello","year":"1998","journal-title":"J Leukoc Biol"},{"issue":"1\u20133","key":"10.1016\/j.cyto.2021.155781_b0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2004.07.012","article-title":"Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention","volume":"500","author":"Muhl","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0220","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.smim.2013.10.014","article-title":"Interleukin-18, more than a Th1 cytokine","volume":"25","author":"Novick","year":"2013","journal-title":"Semin Immunol"},{"key":"10.1016\/j.cyto.2021.155781_b0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: Biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b0235","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","article-title":"The IL-1 family of cytokines and receptors in rheumatic diseases","volume":"15","author":"Dinarello","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0240","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/rheumatology\/40.3.302","article-title":"Expression of interleukin-18 and its monokine-directed function in rheumatoid arthritis","volume":"40","author":"Moller","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0245","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0169-328X(99)00034-0","article-title":"Cultures of astrocytes and microglia express interleukin 18","volume":"67","author":"Conti","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0250","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1046\/j.1471-4159.1999.0722215.x","article-title":"Murine microglial cells produce and respond to interleukin-18","volume":"72","author":"Prinz","year":"1999","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b0255","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q","article-title":"Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development","volume":"28","author":"Stoll","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2021.155781_b0260","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3389\/fimmu.2017.01020","article-title":"Interleukin (IL)-18 Binding Protein Deficiency Disrupts Natural Killer Cell Maturation and Diminishes Circulating IL-18","volume":"8","author":"Harms","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0265","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1034\/j.1399-3003.1999.14c12.x","article-title":"Airway epithelium expresses interleukin-18","volume":"14","author":"Cameron","year":"1999","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0270","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1046\/j.1523-1747.1999.00750.x","article-title":"Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene","volume":"113","author":"Naik","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0275","first-page":"626","article-title":"Regulation of interleukin-18 (IL-18) expression in keratinocytes (HaCaT): implications for early wound healing","volume":"11","author":"K\u00e4mpfer","year":"2000","journal-title":"Eur. Cytokine Netw."},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0280","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s004410050895","article-title":"Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor (\u201cinterleukin-18\u201d) in mouse intestinal epithelial cells","volume":"289","author":"Takeuchi","year":"1997","journal-title":"Cell Tissue Res"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0285","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cell.2015.10.072","article-title":"Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis","volume":"163","author":"Nowarski","year":"2015","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0290","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.4049\/jimmunol.167.12.7038","article-title":"Expression and release of IL-18 binding protein in response to IFN-gamma","volume":"167","author":"Paulukat","year":"2001","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0295","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.185.6.1005","article-title":"Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte\/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation","volume":"185","author":"Udagawa","year":"1997","journal-title":"J Exp Med"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2021.155781_b0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mce.2005.05.011","article-title":"Interleukin-18 is expressed in rat testis and may promote germ cell growth","volume":"240","author":"Strand","year":"2005","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1439-0272.2010.01090.x","article-title":"Presence of IL-18 in testicular tissue of fertile and infertile men","volume":"44","author":"Komsky","year":"2012","journal-title":"Andrologia"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000026445","article-title":"Modulation of IL-18 production in the adrenal cortex following acute ACTH or chronic corticosterone treatment","volume":"8","author":"Conti","year":"2000","journal-title":"NeuroImmunoModulation"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0315","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0169-328X(00)00069-3","article-title":"Detection of the interleukin 18 family in rat brain by RT-PCR","volume":"77","author":"Wheeler","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"issue":"41","key":"10.1016\/j.cyto.2021.155781_b0320","doi-asserted-by":"crossref","first-page":"25737","DOI":"10.1074\/jbc.272.41.25737","article-title":"Purification and characterization of the human interleukin-18 receptor","volume":"272","author":"Torigoe","year":"1997","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.cyto.2021.155781_b0325","doi-asserted-by":"crossref","first-page":"13962","DOI":"10.1073\/pnas.96.24.13962","article-title":"IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils","volume":"96","author":"Yoshimoto","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5\u20136","key":"10.1016\/j.cyto.2021.155781_b0330","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/08830189809043005","article-title":"Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist","volume":"16","author":"Dinarello","year":"1998","journal-title":"Int Rev Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0335","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4049\/jimmunol.165.3.1307","article-title":"IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21","volume":"165","author":"Kalina","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0340","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1189\/jlb.72.2.401","article-title":"Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation","volume":"72","author":"Wyman","year":"2002","journal-title":"J Leukoc Biol"},{"issue":"105","key":"10.1016\/j.cyto.2021.155781_b0345","first-page":"p. cm1","article-title":"Interleukin-1 (IL-1) pathway","volume":"3","author":"Weber","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.cyto.2021.155781_b0350","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbi.2014.02.015","article-title":"Interleukin 18 activates MAPKs and STAT3 but not NF-kappaB in hippocampal HT-22 cells","volume":"40","author":"Alboni","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"23","key":"10.1016\/j.cyto.2021.155781_b0355","doi-asserted-by":"crossref","first-page":"8815","DOI":"10.1073\/pnas.0402800101","article-title":"Differences in signaling pathways by IL-1beta and IL-18","volume":"101","author":"Lee","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0360","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2004-07-2782","article-title":"Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells","volume":"105","author":"Mavropoulos","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0365","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/eji.1830260736","article-title":"Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production","volume":"26","author":"Micallef","year":"1996","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0370","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.158.4.1541","article-title":"IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12","volume":"158","author":"Kohno","year":"1997","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.cyto.2021.155781_b0375","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.188.8.1485","article-title":"Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells","volume":"188","author":"Xu","year":"1998","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0380","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1359-6101(00)00015-0","article-title":"Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu","volume":"12","author":"Nakanishi","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5\u20136","key":"10.1016\/j.cyto.2021.155781_b0390","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cyto.2006.08.006","article-title":"IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation","volume":"35","author":"French","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155781_b0395","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molimm.2017.06.025","article-title":"IL-18\/IL-15\/IL-12 synergy induces elevated and prolonged IFN-gamma production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation","volume":"88","author":"Lusty","year":"2017","journal-title":"Mol Immunol"},{"issue":"9","key":"10.1016\/j.cyto.2021.155781_b0400","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.4049\/jimmunol.162.9.5070","article-title":"IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response","volume":"162","author":"Hoshino","year":"1999","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0405","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.4049\/jimmunol.164.5.2701","article-title":"IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma","volume":"164","author":"Wild","year":"2000","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b0410","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.4049\/jimmunol.1003597","article-title":"Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity","volume":"186","author":"Lalor","year":"2011","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0415","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/art.40099","article-title":"Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by gamma\/delta T Cells in Systemic Juvenile Idiopathic Arthritis","volume":"69","author":"Kessel","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"19","key":"10.1016\/j.cyto.2021.155781_b0420","doi-asserted-by":"crossref","first-page":"E2627","DOI":"10.1073\/pnas.1515793113","article-title":"Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18","volume":"113","author":"Wynn","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0425","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.4049\/jimmunol.159.5.2125","article-title":"A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma","volume":"159","author":"Ahn","year":"1997","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0430","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<1113::AID-IMMU1113>3.0.CO;2-P","article-title":"The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit","volume":"30","author":"Chang","year":"2000","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0435","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4049\/jimmunol.168.3.1146","article-title":"Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1","volume":"168","author":"Nakahira","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0440","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/77811","article-title":"IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6","volume":"1","author":"Yoshimoto","year":"2000","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0445","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1074-7613(00)80543-9","article-title":"Defective NK cell activity and Th1 response in IL-18-deficient mice","volume":"8","author":"Takeda","year":"1998","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0450","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4049\/jimmunol.162.3.1662","article-title":"IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor","volume":"162","author":"Hyodo","year":"1999","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0455","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1128\/IAI.68.12.6932-6938.2000","article-title":"Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii","volume":"68","author":"Cai","year":"2000","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0460","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nm1415","article-title":"Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance","volume":"12","author":"Netea","year":"2006","journal-title":"Nat Med"},{"issue":"26","key":"10.1016\/j.cyto.2021.155781_b0465","doi-asserted-by":"crossref","first-page":"11097","DOI":"10.1073\/pnas.0611523104","article-title":"Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency","volume":"104","author":"Zorrilla","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0470","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cmet.2015.09.024","article-title":"IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic Syndrome","volume":"23","author":"Murphy","year":"2016","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0475","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1073\/pnas.97.3.1190","article-title":"Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18","volume":"97","author":"Kim","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2021.155781_b0480","doi-asserted-by":"crossref","unstructured":"Halim, A., et al., Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD. Mol Cell Proteomics, 2012. 11(4): p. M111 013649.","DOI":"10.1074\/mcp.M111.013649"},{"issue":"26","key":"10.1016\/j.cyto.2021.155781_b0485","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1073\/pnas.262663399","article-title":"The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT\/enhancer binding protein beta","volume":"99","author":"Hurgin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8B","key":"10.1016\/j.cyto.2021.155781_b0490","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/j.1582-4934.2008.00604.x","article-title":"Molecular mechanisms of IL-18BP regulation in DLD-1 cells: pivotal direct action of the STAT1\/GAS axis on the promoter level","volume":"13","author":"Bachmann","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0495","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbagrm.2018.01.020","article-title":"Epigenetic regulation by CpG methylation splits strong from retarded IFNgamma-induced IL-18BP in epithelial versus monocytic cells","volume":"1861","author":"Bachmann","year":"2018","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0500","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.4049\/jimmunol.168.7.3608","article-title":"IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease","volume":"168","author":"Corbaz","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0505","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/keg146","article-title":"Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes","volume":"42","author":"Moller","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0510","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.27269","article-title":"Blocking ERK-1\/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A","volume":"62","author":"Marotte","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038751","article-title":"IL-27 Regulates IL-18 binding protein in skin resident cells","volume":"7","author":"Wittmann","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0520","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1006\/bbrc.1999.2064","article-title":"Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells","volume":"267","author":"Muhl","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0525","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.4049\/jimmunol.168.5.2282","article-title":"IL-12 induces monocyte IL-18 binding protein expression via IFN-gamma","volume":"168","author":"Veenstra","year":"2002","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b0530","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","article-title":"Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome","volume":"106","author":"Mazodier","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008663","article-title":"Failure of interferon gamma to induce the anti-inflammatory interleukin 18 binding protein in familial hemophagocytosis","volume":"5","author":"Nold-Petry","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2021.155781_b0540","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3389\/fimmu.2019.02014","article-title":"Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases","volume":"10","author":"Barbier","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0545","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/cyto.2001.0914","article-title":"A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18","volume":"14","author":"Novick","year":"2001","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0550","first-page":"27","article-title":"Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease","volume":"16","author":"Ludwiczek","year":"2005","journal-title":"Eur Cytokine Netw"},{"issue":"11","key":"10.1016\/j.cyto.2021.155781_b0555","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.162.11.6829","article-title":"IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells","volume":"162","author":"Pizarro","year":"1999","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0560","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2001.28021","article-title":"Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease","volume":"121","author":"Kanai","year":"2001","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0565","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gut.50.6.812","article-title":"Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage","volume":"50","author":"Sivakumar","year":"2002","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b0570","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI7317","article-title":"A proinflammatory role for IL-18 in rheumatoid arthritis","volume":"104","author":"Gracie","year":"1999","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.cyto.2021.155781_b0575","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/ard.61.8.726","article-title":"Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis","volume":"61","author":"Bresnihan","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0580","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10238-009-0036-2","article-title":"Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis","volume":"9","author":"Shao","year":"2009","journal-title":"Clin Exp Med"},{"issue":"11","key":"10.1016\/j.cyto.2021.155781_b0585","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.4049\/jimmunol.165.11.6553","article-title":"An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis","volume":"165","author":"Joosten","year":"2000","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0590","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1172\/JCI200112097","article-title":"Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis","volume":"108","author":"Plater-Zyberk","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0595","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4049\/jimmunol.166.1.517","article-title":"Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18","volume":"166","author":"Wei","year":"2001","journal-title":"J Immunol"},{"issue":"24","key":"10.1016\/j.cyto.2021.155781_b0600","doi-asserted-by":"crossref","first-page":"14181","DOI":"10.1073\/pnas.2336094100","article-title":"IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease","volume":"100","author":"Bossu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0605","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10067-010-1386-6","article-title":"Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients","volume":"29","author":"Hu","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.cyto.2021.155781_b0610","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ni1377","article-title":"Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation","volume":"7","author":"Gutcher","year":"2006","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.cyto.2021.155781_b0615","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/1352458510364634","article-title":"Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis","volume":"16","author":"Gillett","year":"2010","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0620","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.4049\/jimmunol.0902153","article-title":"Inflammation in the central nervous system and Th17 responses are inhibited by IFN-gamma-Induced IL-18 binding protein","volume":"185","author":"Millward","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0625","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/00015550310016508","article-title":"Interleukin-18 levels in the plasma of psoriatic patients correlate with the extent of skin lesions and the PASI score","volume":"83","author":"Pietrzak","year":"2003","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0630","doi-asserted-by":"crossref","first-page":"713","DOI":"10.5114\/aoms.2011.24144","article-title":"Interleukin-18 expression and the response to treatment in patients with psoriasis","volume":"7","author":"Rasmy","year":"2011","journal-title":"Arch Med Sci"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0635","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00403-017-1735-2","article-title":"Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia","volume":"309","author":"Shimoura","year":"2017","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0640","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03191127","article-title":"Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis","volume":"31","author":"Tak","year":"2006","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0645","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I","article-title":"Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease","volume":"44","author":"Kawaguchi","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0650","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","article-title":"Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease","volume":"44","author":"Kawashima","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0655","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory adult-onset Still's disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.cyto.2021.155781_b0660","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/art.23088","article-title":"Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease","volume":"57","author":"Chen","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0665","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/acr.22194","article-title":"Clinical manifestations of Adult-onset Still's disease presenting with erosive arthritis: Association with low levels of ferritin and Interleukin-18","volume":"66","author":"Ichida","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.cyto.2021.155781_b0670","article-title":"Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b0675","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3899\/jrheum.111500","article-title":"Natural killer cell cytolytic function in Korean patients with adult-onset Still's disease","volume":"39","author":"Park","year":"2012","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.cyto.2021.155781_b0680","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.cyto.2021.155781_b0685","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0690","first-page":"1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease","volume":"40","author":"Fujii","year":"2001","journal-title":"Association with chronic articular disease. Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2021.155781_b0695","article-title":"IL-18 Serum Level in Adult Onset Still's Disease: A Marker of Disease Activity","volume":"2012","author":"Colafrancesco","year":"2012","journal-title":"Int J Inflam"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0700","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2008.093781","article-title":"Lymph node IL-18 expression in adult-onset Still's disease","volume":"68","author":"Conigliaro","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0705","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/03009742.2013.824023","article-title":"Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease","volume":"43","author":"Jung","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0710","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clim.2004.03.023","article-title":"Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile","volume":"112","author":"Saiki","year":"2004","journal-title":"Clin Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b0715","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3899\/jrheum.181192","article-title":"Characteristics of Circulating Natural Killer Cells and Their Interferon-gamma Production in Active Adult-onset Still Disease","volume":"46","author":"Shimojima","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2021.155781_b0720","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue","year":"2016","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0725","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-020-02200-4","article-title":"Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis","volume":"22","author":"Koga","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0730","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3899\/jrheum.120079","article-title":"Serum S100A8\/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease","volume":"39","author":"Kim","year":"2012","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0735","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/rheumatology\/keq397","article-title":"Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis","volume":"50","author":"Priori","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0740","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0745","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2021.155781_b0750","doi-asserted-by":"crossref","unstructured":"Maeno, N., et al., Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. Arthritis Rheum, 2002. 46(9): p. 2539-41; author reply 2541-2.","DOI":"10.1002\/art.10389"},{"issue":"8","key":"10.1016\/j.cyto.2021.155781_b0755","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s10067-006-0474-0","article-title":"Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis","volume":"26","author":"Jelusic","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.cyto.2021.155781_b0760","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0765","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cyto.2012.05.003","article-title":"Compensated inflammation in systemic juvenile idiopathic arthritis: role of alternatively activated macrophages","volume":"60","author":"Shimizu","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0770","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cyto.2012.11.025","article-title":"Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles","volume":"61","author":"Shimizu","year":"2013","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0775","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","article-title":"Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"160","author":"Shimizu","year":"2015","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.cyto.2021.155781_b0780","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","article-title":"Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"de Jager","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.cyto.2021.155781_b0785","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","article-title":"Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-gamma","volume":"54","author":"Put","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0790","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.39933","article-title":"Inflammatory Gene Expression Profile and Defective Interferon-gamma and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients","volume":"69","author":"Put","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0795","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/abbs\/gmt007","article-title":"The imbalance of IL-18\/IL-18BP in patients with systemic juvenile idiopathic arthritis","volume":"45","author":"Chen","year":"2013","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0800","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b0805","first-page":"823","article-title":"Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis","volume":"34","author":"Lotito","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0810","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","article-title":"Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6","volume":"58","author":"Shimizu","year":"2012","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0815","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1002\/pbc.24480","article-title":"Cytokine profiles in children with primary Epstein-Barr virus infection","volume":"60","author":"Wada","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cyto.2021.155781_b0820","article-title":"Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers. Arthritis","author":"Kessel","year":"2021","journal-title":"Rheumatol"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b0825","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0830","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0835","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2013.09.007","article-title":"Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency","volume":"65","author":"Wada","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155781_b0840","article-title":"Excess Serum Interleukin-18 Distinguishes Patients with Pathogenic Mutations in PSTPIP1. Arthritis","author":"Stone","year":"2021","journal-title":"Rheumatol"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b0845","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1084\/jem.20190147","article-title":"A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function","volume":"216","author":"Lam","year":"2019","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0850","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0855","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbspin.2018.03.010","article-title":"Biological agents in the management of adult-onset Still's disease","volume":"86","author":"Girard-Guyonvarc'h","year":"2019","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0860","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2012.07.022","article-title":"Systemic juvenile idiopathic arthritis","volume":"12","author":"Martini","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0865","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions","volume":"7","author":"Mellins","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0870","first-page":"653","article-title":"Interleukin 6: a possible marker of disease activity in adult onset Still's disease","volume":"14","author":"Scheinberg","year":"1996","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.cyto.2021.155781_b0875","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis","volume":"34","author":"de Benedetti","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0880","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.semarthrit.2017.06.006","article-title":"Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)","volume":"47","author":"Junge","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.cyto.2021.155781_b0885","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0890","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10067-003-0775-5","article-title":"Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients","volume":"23","author":"Kokkinos","year":"2004","journal-title":"Clin Rheumatol"},{"issue":"45","key":"10.1016\/j.cyto.2021.155781_b0895","doi-asserted-by":"crossref","first-page":"19432","DOI":"10.1073\/pnas.1010603107","article-title":"Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation","volume":"107","author":"Kawane","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0900","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/art.38359","article-title":"Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund's complete adjuvant: regulation by interferon-gamma","volume":"66","author":"Avau","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0905","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00296-014-3059-2","article-title":"Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease","volume":"35","author":"Takahara","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cyto.2021.155781_b0910","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41927-019-0053-z","article-title":"Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity","volume":"3","author":"Kudela","year":"2019","journal-title":"BMC Rheumatol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0915","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/art.20268","article-title":"Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome","volume":"50","author":"Maeno","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b0920","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.gene.6363922","article-title":"Association between adult-onset Still's disease and interleukin-18 gene polymorphisms","volume":"3","author":"Sugiura","year":"2002","journal-title":"Genes Immun"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0925","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar1930","article-title":"A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population","volume":"8","author":"Sugiura","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"9927","key":"10.1016\/j.cyto.2021.155781_b0930","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2021.155781_b0935","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The Immunology of Macrophage Activation Syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0940","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40272-019-00367-1","article-title":"Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management","volume":"22","author":"Henderson","year":"2020","journal-title":"Paediatr Drugs"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b0945","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cyto.2021.155781_b0950","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3389\/fimmu.2017.01102","article-title":"How Viruses Contribute to the Pathogenesis of Hemophagocytic Lymphohistiocytosis","volume":"8","author":"Brisse","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b0955","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0960","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/rheumatology\/key006","article-title":"Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment","volume":"58","author":"Carter","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b0965","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1073\/pnas.0509054103","article-title":"Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo","volume":"103","author":"Yang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"26","key":"10.1016\/j.cyto.2021.155781_b0970","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1182\/blood-2013-04-495309","article-title":"Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells","volume":"121","author":"Terrell","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cyto.2021.155781_b0975","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0980","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.40438","article-title":"Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-kappaB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis","volume":"70","author":"Schulert","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b0985","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0990","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b0995","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jaci.2014.11.030","article-title":"Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-gamma receptor deficiency","volume":"135","author":"Tesi","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b1000","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.cyto.2021.155781_b1005","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","article-title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","volume":"131","author":"Girard-Guyonvarc'h","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2021.155781_b1010","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/art.33496","article-title":"Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome","volume":"64","author":"Strippoli","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.cyto.2021.155781_b1015","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1016\/S2665-9913(21)00139-9","article-title":"Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study","volume":"3","author":"Rodriguez-Smith","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"5446","key":"10.1016\/j.cyto.2021.155781_b1020","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b1025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2021.155781_b1030","doi-asserted-by":"crossref","unstructured":"zur Stadt, U., et al., Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum. Mol. Genet., 2005. 14(6): p. 827-34.","DOI":"10.1093\/hmg\/ddi076"},{"key":"10.1016\/j.cyto.2021.155781_b1035","doi-asserted-by":"crossref","unstructured":"zur Stadt, U., et al., Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet, 2009. 85(4): p. 482-92.","DOI":"10.1016\/j.ajhg.2009.09.005"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b1040","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"Cote","year":"2009","journal-title":"J Clin Invest"},{"issue":"6588","key":"10.1016\/j.cyto.2021.155781_b1045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/382262a0","article-title":"Identification of the homologous beige and Chediak-Higashi syndrome genes","volume":"382","author":"Barbosa","year":"1996","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b1050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/76024","article-title":"Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome","volume":"25","author":"Menasche","year":"2000","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b1055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood-2005-11-4413","article-title":"Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II","volume":"108","author":"Enders","year":"2006","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.cyto.2021.155781_b1060","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis","volume":"135","author":"Canna","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2021.155781_b1065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fimmu.2013.00448","article-title":"Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice","volume":"4","author":"Jessen","year":"2013","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b1070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.20140964","article-title":"Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time","volume":"212","author":"Jenkins","year":"2015","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.cyto.2021.155781_b1075","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood-2014-09-602946","article-title":"A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice","volume":"125","author":"Sepulveda","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b1080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cei.13543","article-title":"The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome - a systematic review","volume":"203","author":"Krei","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"19","key":"10.1016\/j.cyto.2021.155781_b1085","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood.2019003846","article-title":"Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation","volume":"136","author":"Tsoukas","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2021.155781_b1090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fimmu.2012.00239","article-title":"Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein","volume":"3","author":"Chiossone","year":"2012","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2021.155781_b1095","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.4049\/jimmunol.1701628","article-title":"Deletion of Inflammasome Components Is Not Sufficient To Prevent Fatal Inflammation in Models of Familial Hemophagocytic Lymphohistiocytosis","volume":"200","author":"Fauteux-Daniel","year":"2018","journal-title":"J Immunol"},{"issue":"7115","key":"10.1016\/j.cyto.2021.155781_b1100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2021.155781_b1105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2015.01.015","article-title":"XIAP deficiency syndrome in humans","volume":"39","author":"Latour","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.cyto.2021.155781_b1110","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","article-title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b1115","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","article-title":"XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation","volume":"7","author":"Yabal","year":"2014","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b1120","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.celrep.2017.06.073","article-title":"XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1beta Activation and Cell Death as a Consequence of TLR-MyD88-Induced cIAP1-TRAF2 Degradation","volume":"20","author":"Lawlor","year":"2017","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b1125","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41419-019-1938-x","article-title":"TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP","volume":"10","author":"Knop","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cyto.2021.155781_b1130","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1038\/ncomms7282","article-title":"RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL","volume":"6","author":"Lawlor","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.cyto.2021.155781_b1135","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3389\/fimmu.2020.01840","article-title":"Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18","volume":"11","author":"Alehashemi","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b1140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.cyto.2021.155781_b1145","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.cyto.2021.155781_b1150","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.cyto.2021.155781_b1155","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/ACI.0000000000000396","article-title":"NLRC4 inflammasomopathies","volume":"17","author":"Romberg","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2021.155781_b1160","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.39960","article-title":"Identification of a High-Frequency Somatic NLRC4 Mutation as a Cause of Autoinflammation by Pluripotent Cell-Based Phenotype Dissection","volume":"69","author":"Kawasaki","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.cyto.2021.155781_b1165","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4 causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.cyto.2021.155781_b1170","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjd.14757","article-title":"Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype","volume":"176","author":"Volker-Touw","year":"2017","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.cyto.2021.155781_b1175","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10875-020-00785-8","article-title":"The Growing Spectrum of Human Diseases Caused by Inherited CDC42 Mutations","volume":"40","author":"Su","year":"2020","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2021.155781_b1180","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/fty020","article-title":"The pyrin inflammasome: from sensing RhoA GTPases-inhibiting toxins to triggering autoinflammatory syndromes","volume":"76","author":"Jamilloux","year":"2018","journal-title":"Pathog Dis"},{"key":"10.1016\/j.cyto.2021.155781_b1185","doi-asserted-by":"crossref","unstructured":"Gernez, Y., et al., Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1beta inhibition. J Allergy Clin Immunol, 2019. 144(4): p. 1122-1125 e6.","DOI":"10.1016\/j.jaci.2019.06.017"},{"issue":"8","key":"10.1016\/j.cyto.2021.155781_b1190","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder","volume":"11","author":"Wise","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"23","key":"10.1016\/j.cyto.2021.155781_b1195","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.2135380100","article-title":"Pyrin binds the PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway","volume":"100","author":"Shoham","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621003707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621003707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:44:25Z","timestamp":1760910265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621003707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":239,"alternative-id":["S1043466621003707"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155781","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Balance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"155781"}}